AEG-35156

N/A

Report date: 2022/11/25 18:11:05
NME

Base Information

Drug NameAEG-35156
Drug Alias NameAEG-161GEM-640AEG-35156
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionInhibitor of apoptosis protein 3 inhibitors
TargetsInhibitor of apoptosis protein 3
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungBreast NeoplasmsCarcinoma, Hepatocellular +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesGermany +[5] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAceragen Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAegera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungBreast NeoplasmsCarcinoma, Hepatocellular +[9] 

Other Information

ATC CodeN/A
Related LinksN/A